GXV813

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GXV813, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia [Phase 2]

See pricing